Primary Record
Hycon
- In stock
- 5,286 g
- Purity
- 98.3 %
- CAS
- 143-71-5
Compound Identifiers & Properties
- CAS
- 143-71-5
- PubChem CID
- 5463977
- SMILES
- CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- Canonical SMILES
- COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O=C(O)[C@H](O)[C@@H](O)C(=O)O
Names & Synonyms
- Hycon
- Mercodinone
- Biocodone
- Dicodethal
- Dicodrine
- Dicotrate
- Stodcodon
- Hydrokon
- Robidone
- Synkonin
- Codone
- Brocodid longum
- HYDROCODONE BITARTRATE
- Hysingla
- Zohydro
- Vicoprofen
- Codamine
- Codinovo
- Hycomine
- Hydrocet
- Hysingla ER
- Anexsia
- Hycodan
- Tycolet
- Vicodin
- Lortab
- Norcet
- Zohydro ER
- Allay
- Norco
- Vicodin Hp
- Lorcet-Hd
- Vantrela ER
- Duradyne DHC
- Co-Gesic
- Vicodin ES
- Bancap HC
- Hy-Phen
- Hycomine Pediatric
- Dihydrocodeinone tartrate
- AZDONE
- Dihydrocodeinone bitartrate
- HYDROPANE
- MYCODONE
- TUSSIGON
- VICOPRIN
- Hydrocodone hydrogen tartrate
- Dihydrocodeinone acid tartrate
- Hydrocodone (bitartrate)
- HYDROCODONE COMPOUND
- Dihydrocodeinone hydrogen tartrate
- UNII-9GU1G05Y03
- Hydrocodone Bitartrate (anhydrous)
- Hydrocodone (+)-bitartrate salt
- ANEXSIA 5/325
- EINECS 205-608-1
- C18H21NO3.C4H6O6
- 9GU1G05Y03
- ANEXSIA 10/660
- ANEXSIA 7.5/325
- ANEXSIA 7.5/650
- SCHEMBL29358753
- DTXSID40162277
- DEXAMETHASONESODIUMPHOSPHATE
- OJHZNMVJJKMFGX-BWCYBWMMSA-N
- 143-71-5
- Hydrocodone hydrogen tartrate 2.5
- HYDROCODONE BITARTRATE ANHYDROUS
- CID5463977
- HYDROCODONE BITARTRATE, ANHYDROUS
- AN-23265
- LS-92160
- Hydrocodone bitartrate (anhydrous) [USAN]
- Hydrocodone Hydrogen Tartrate 2.5-Hydrate
- C18-H21-N-O3.C4-H6-O6
- HYDROCODONE BITARTRATE ANHYDROUS [MI]
- NS00076286
- ACETAMINOPHEN AND HYDROCODONE BITARTRATE
- HYDROCODONE BITARTRATE AND ACETAMINOPHEN
- Q27272536
- HOMATROPRINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
- HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
- Morphinan-6-one, 4,5alpha-epoxy-3-methoxy-17-methyl-, tartrate(1:1)
- Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
- (4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;(2R,3R)-2,3-dihydroxybutanedioic acid
- Morphinan-6-one, 4,5-alpha-epoxy-3-methoxy-17-methyl-, tartrate (1:1)
- Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5?)-, [R-(R,R)]-2,3-dihydroxybutanedioate (1:1)
- Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha)-, (theta-(theta,theta))-2,3-dihydroxybutanedioate (1:1)
- 4,5.ALPHA.-EPOXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE TARTRATE (1:1)
- (2R,3R)-2,3-Dihydroxybutanedioic acid--3-methoxy-17-methyl-5alpha-4,5-epoxymorphinan-6-one (1/1)
- 34195-34-1
- 4,5-Epoxy-3-methoxy-17-methyl-5|A-morphinan-6-one (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- MORPHINAN-6-ONE, 4,5-EPOXY-3-METHOXY-17-METHYL-, (5.ALPHA.)-, (R-(R*,R*))-2,3-DIHYDROXYBUTANEDIOATE (1:1)